中文名稱:小鼠抗CA19-9單克隆抗體
Background: |
CA 19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis (a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. CA 19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. Apart from cancer, elevated levels may also occur in pancreatitis, cirrhosis, and diseases of the bile ducts. It can be elevated in people with obstruction of the bile ducts. |
Applications: |
IHC |
Name of antibody: |
CA19-9 |
Immunogen: |
SW1116 human colon carcinoma cell line |
Full name: |
CA19-9 |
IHC positive control: |
carcinoma of human lung tissue and carcinoma of human bladder tissue |
IHC Recommend dilution: |
30-150 |